These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28847456)

  • 1. The response of substance use disorder treatment providers to changes in macroeconomic conditions.
    Cantor J; Stoller KB; Saloner B
    J Subst Abuse Treat; 2017 Oct; 81():59-65. PubMed ID: 28847456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth in spending on substance use disorder treatment services for the privately insured population.
    Thomas CP; Hodgkin D; Levit K; Mark TL
    Drug Alcohol Depend; 2016 Mar; 160():143-50. PubMed ID: 26781063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of macroeconomic conditions on the care decisions of the employed.
    Hughes DR; Khaliq AA
    Med Care; 2014 Feb; 52(2):121-7. PubMed ID: 24309667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State parity laws and access to treatment for substance use disorder in the United States: implications for federal parity legislation.
    Wen H; Cummings JR; Hockenberry JM; Gaydos LM; Druss BG
    JAMA Psychiatry; 2013 Dec; 70(12):1355-62. PubMed ID: 24154931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Special Services for Women in Substance Use Disorders Treatment: How Does the Department of Veterans Affairs Compare with Other Providers?
    Heslin KC; Gable A; Dobalian A
    Womens Health Issues; 2015; 25(6):666-72. PubMed ID: 26329259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and impact of bundled payment for detox and follow-up care.
    Quinn AE; Hodgkin D; Perloff JN; Stewart MT; Brolin M; Lane N; Horgan CM
    J Subst Abuse Treat; 2017 Nov; 82():113-121. PubMed ID: 29021109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance Use Treatment Provider Behavior and Healthcare Reform: Evidence from Massachusetts.
    Maclean JC; Saloner B
    Health Econ; 2018 Jan; 27(1):76-101. PubMed ID: 28224675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in Medicaid Acceptance by Substance Abuse Treatment Facilities After Implementation of Federal Parity.
    Geissler KH; Evans EA
    Med Care; 2020 Feb; 58(2):101-107. PubMed ID: 31688556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of accountable care and payment reform on substance use disorder treatment: evidence from the initial 3 years of the alternative quality contract.
    Stuart EA; Barry CL; Donohue JM; Greenfield SF; Duckworth K; Song Z; Mechanic R; Kouri EM; Ebnesajjad C; Chernew ME; Huskamp HA
    Addiction; 2017 Jan; 112(1):124-133. PubMed ID: 27517740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in drug treatment services based on profit status.
    Montoya ID
    J Psychoactive Drugs; 2006 Sep; 38(3):219-28. PubMed ID: 17165364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance Use Disorder Treatment Services for Women in the Veterans Health Administration.
    Timko C; Hoggatt KJ; Wu FM; Tjemsland A; Cucciare M; Rubin A; Simpson TL
    Womens Health Issues; 2017; 27(6):639-645. PubMed ID: 28602581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. State-level unemployment and the utilization of preventive medical services.
    Tefft N; Kageleiry A
    Health Serv Res; 2014 Feb; 49(1):186-205. PubMed ID: 23855636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining facilitative services for entry into substance use disorder treatment: A cluster analysis of treatment facilities.
    Amoako EO; Zerden LD; Hughes TD; Gertner AK; Williams J; Belden CM; Ware OD
    PLoS One; 2024; 19(5):e0304094. PubMed ID: 38781169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral Health Outcomes Among Adults: Associations With Individual and Community-Level Economic Conditions.
    Dunlap LJ; Han B; Dowd WN; Cowell AJ; Forman-Hoffman VL; Davies MC; Colpe LJ
    Psychiatr Serv; 2016 Jan; 67(1):71-7. PubMed ID: 26325454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New systems of care for substance use disorders: treatment, finance, and technology under health care reform.
    Pating DR; Miller MM; Goplerud E; Martin J; Ziedonis DM
    Psychiatr Clin North Am; 2012 Jun; 35(2):327-56. PubMed ID: 22640759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of health care costs associated with depression and substance abuse in a national sample.
    Druss BG; Rosenheck RA
    Psychiatr Serv; 1999 Feb; 50(2):214-8. PubMed ID: 10030479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why health insurers should pay for addiction treatment. Treatment works and would lead to net societal benefits.
    Breithaupt D
    West J Med; 2001 Jun; 174(6):375-7. PubMed ID: 11380993
    [No Abstract]   [Full Text] [Related]  

  • 18. Is it feasible to pay specialty substance use disorder treatment programs based on patient outcomes?
    Hodgkin D; Garnick DW; Horgan CM; Busch AB; Stewart MT; Reif S
    Drug Alcohol Depend; 2020 Jan; 206():107735. PubMed ID: 31790980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transit and treatment: Aligning systems to address substance use in Connecticut.
    Cohen JP; Huleatt S; Murphy S; Rash CJ
    Health Serv Res; 2024 Feb; 59 Suppl 1(Suppl 1):e14268. PubMed ID: 38128579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locations of facilities with special programs for older substance abuse clients in the US.
    Schultz SK; Arndt S; Liesveld J
    Int J Geriatr Psychiatry; 2003 Sep; 18(9):839-43. PubMed ID: 12949852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.